Karista | Investing in Game Changers

OUR WAY

Karista is an early-stage venture capital firm created in 2001. We funded 90+ companies over the past two decades and support tomorrow’s game changers in the field of Health, Digital, Tech, and NewSpace.

We have always worked to provide more than cash and partnered with entrepreneurs whom we share a common vision with.

OUR WAY

OUR COMPANIES

Vestack

Tech

By combining digital design, bio-based materials, and modular manufacturing, Vestack is a PropTech company producing buildings faster and at lower cost, while drastically reducing the building’s environmental footprint.

Exotrail

Tech

Exotrail’s mission is to deliver agility to the space industry. The company provides mission simulation and operation software, high thrust and flexible electric propulsion systems, and on-orbit transfer vehicles.

MyPL

Healthcare

MyPL develops a breakthrough patient data visualization solution. Designed with and for medical experts in oncology, their dashboard enables the automatic reconstruction of a patient’s clinical file, presenting his or her health data structured and qualified by the experts.

NEWS

— ALL NEWS & Insights

Apr 15 th, 2021

Karista strengthens its governance with the appointment of Yvan-Michel Ehkirch at its Executive Board

In order to support its European development strategy in several investment sectors, Karista announces the appointment of Yvan-Michel Ehkirch as a new member of its Executive Board

Mar 29 th, 2021

Active European Digital Health Funds Mapping by Karista

63% of the companies active in Digital Health throughout Europe were created in the last 5 years. In respond to the rapid growth of the sector, Karista publishes for the first time a European mapping of Digital Health funds (known as “e-health”).

Mar 18 th, 2021

Karista invests in MyPL increasing its financing to €1.8m

Karista invests in MyPL (My Personal Lifescope) increasing its financing to €1.8m. This transaction allows MyPL to drive the development of its personalized augmented medicine platform in France and internationally, and to carry out the first implementations in hospitals.